In-vitro method for determining a surreptitious use of exogenous

Details In-vitro method for determining a surreptitious use of exogenous In-vitro method for determining a surreptitious use of exogenous

1992-08-17

1994-11-29

Wityshyn, Michael G.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving viable micro-organism

435 725, 435 76, 436817, 436901, C12Q 102, C12Q 100

Patent

active

053690141

ABSTRACT:
The present invention is an in-vitro blood assay method for determining the past and/or present use of exogenous erythropoietin by a living subject. The blood assay method detects, identifies, and determines the consequences of using an exogenous erythropoietin to generate an increase in red blood cell production in the living subject and provides a methodology by which to detect and determine both surreptitious as well as authorized therapeutic uses and applications of erythropoietin.

REFERENCES:
patent: 4558005 (1985-12-01), Goldwasser

Affiliated with

Also associated with

Rating

In-vitro method for determining a surreptitious use of exogenous does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with In-vitro method for determining a surreptitious use of exogenous, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In-vitro method for determining a surreptitious use of exogenous will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-73522